Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

predALZ: An Ensemble Learning Framework for Identifying Genetic Biomarkers in Familial Alzheimer's Disease.

Current drug targets·2026
Same author

XCPP: A Multi-model Explainable Deep Learning Framework for Accurate Identification of Cell-Penetrating Peptides from Structured Sequence Features.

Current drug targets·2026
Same author

Deep learning based prediction of RNA 5hmC modifications using composite feature representations and comparative benchmarking with transformer models.

BioData mining·2026
Same author

An effective approach to improving photovoltaic defect detection using the new DCD-YOLOv8s model.

Scientific reports·2025
Same author

An ensemble strategy for piRNA identification through hybrid moment-based feature modeling.

Scientific reports·2025
Same author

Diaproteo: A supervised learning framework for early detection of diabetes mellitus based on proteomic profiles.

Digital health·2025

Related Experiment Video

Updated: Nov 2, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.7K

Evaluating machine learning methodologies for identification of cancer driver genes.

Sharaf J Malebary1, Yaser Daanial Khan2

  • 1Department of Information Technology, Faculty of Computing and Information Technology, King Abdulaziz University, P.O. Box 344, Rabigh, 21911, Saudi Arabia.

Scientific Reports
|June 11, 2021
PubMed
Summary

Identifying cancer driver genes is crucial for oncology. This study introduces PCDG-Pred, a novel model that accurately distinguishes driver genes from passenger genes in large sequencing datasets, outperforming existing methods.

More Related Videos

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.4K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.6K

Related Experiment Videos

Last Updated: Nov 2, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.7K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.4K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.6K

Area of Science:

  • Genomics
  • Bioinformatics
  • Cancer Research

Background:

  • Cancer development is linked to specific genetic alterations.
  • Accurate identification of cancer driver genes is essential for oncological analysis and treatment.
  • Existing methods for driver gene identification often rely on frequency and lack efficiency on large datasets.

Purpose of the Study:

  • To propose an efficient computational model, PCDG-Pred, for distinguishing cancer driver genes from passenger genes using sequencing data.
  • To provide a robust utility for prioritizing biologically active driver mutations over inert passenger mutations in high-throughput cancer sequencing data.

Main Methods:

  • Development of the PCDG-Pred model for analyzing gene sequencing data.
  • Application of various validation techniques including self-consistency, independent set, and cross-validation.
  • Evaluation of model performance using metrics such as accuracy, Matthews correlation coefficient, sensitivity, and specificity.

Main Results:

  • PCDG-Pred demonstrates a significant functional advantage over existing cancer driver gene identification strategies.
  • High accuracy metrics were achieved: 91.08% for self-consistency, 87.26% for independent set, and 92.48% for cross-validation.

Conclusions:

  • The proposed PCDG-Pred model offers an effective and accurate approach for identifying cancer driver genes from sequencing data.
  • This method provides a valuable tool for advancing oncological analysis and understanding cancer biology.